巴西圣保罗三级转诊中心儿童葡萄膜炎的临床特征
双眼受累占89.7%、无症状占56.4%、复发/慢性占84.6%;前葡萄膜炎最常见(46%),JIA相关葡萄膜炎占41%。初次就诊时46%有眼部并发症,最终评估时达90%;非感染性病例均使用全身免疫抑制治疗,84%视力改善或保持。
要点
- 儿童葡萄膜炎以双眼、无症状、复发/慢性为主,前葡萄膜炎最常见。
- JIA相关葡萄膜炎占41%,免疫介导中间葡萄膜炎占25.6%。
- 眼部并发症初诊时46%,最终评估时90%;84%视力改善或保持。
核心结论
- 儿童葡萄膜炎患者早期转诊至该中心,尽管病情严重,适当的全身免疫抑制治疗可能保持视力。
研究设计与样本
- 回顾性 Review 2017年4月至9月于巴西圣保罗大学医学院附属医院葡萄膜炎门诊就诊的16岁以下患者临床记录。
主要发现
- 双眼受累占89.7%,无症状占56.4%,复发/慢性病例占84.6%。
- 纳入时平均年龄10.7±3.4岁(范围3-16岁)。
- 27例(84%)视力改善或保持,8例视力信息未报告。
- 55%在葡萄膜炎诊断后6个月内转诊至三级中心。
- 前葡萄膜炎占46%,中间葡萄膜炎占26%;JIA相关葡萄膜炎占41%,免疫介导中间葡萄膜炎占25.6%;眼弓形虫病占7.7%,弓蛔虫病占5.1%。
关键数值与推荐
- 所有非感染性病例(32例,82%)使用口服泼尼松、免疫抑制治疗(IMT)和/或生物制剂。
- 所有JIA相关葡萄膜炎患者及50%免疫介导中间葡萄膜炎患者使用IMT和/或生物制剂。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To analyse the clinical features, systemic associations, treatment and visual outcomes of uveitis in children from a referral centre in São Paulo, Brazil. METHODS: Clinical records of patients under 16 years old who attended the Uveitis Service, Hospital das Clinicas, Faculdadede Medicina, Universidade de São PauloFMUSP, between April and September 2017, were reviewed retrospectively. Patients with incomplete medical records, previous ocular trauma, or less than six6 months of follow-up were excluded. RESULTS: Thirty-nine children (25 female/14 male) were included. There was predominance of bilateral (89.7%), asymptomatic (56.4%) and recurrent/chronic cases (84.6%). The mean age at study inclusion was 10.7±3.4 years (range 3-16 years). Improvement or preservation of visual acuity (VA) was observed in 27 patients (84%); VA was not informed in 8 patients. Patients were referred early to tertiary centre (55% within 6 months of uveitis diagnosis). Anterior uveitis was the most common involvement (46%), followed by intermediate uveitis (26%). Juvenile idiopathic arthritis (JIA)-associated uveitis (41%) and immune-mediated intermediate uveitis (25.6%) were the principal non-infectious conditions; ocular toxoplasmosis (7.7%) and toxocariasis (5.1%) were the most common infectious conditions. Ocular complications were observed at first visit in 46% of patients and in 90% during final evaluation. Oral prednisone, immunosuppressive therapy (IMT) and/or biologic agents were used in all non-infectious conditions (32 children, 82%); IMT and/or biologic agents were used in all patients with JIA-associated uveitis and in 50% of patients with immune-mediated intermediate uveitis. CONCLUSION: Paediatric patients with uveitis are referred early to this centre and, although severe, adequate management with systemic IMT may preserve VA.
引用
- Souto FMS, Giampietro BV, Takiuti JT, et al. Clinical features of paediatric uveitis at a tertiary referral centre in São Paulo, SP, Brazil. Br J Ophthalmol. 2018. PMID: 29907630. doi:10.1136/bjophthalmol-2018-312313
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。